In this video, the first in a 5-part series, panelists discuss recent advancements in bronchiectasis management.
RX Review: A New Era of Disease-Modifying Therapy for Bronchiectasis
In this video, the second in a 5-part series, panelists discuss the recent FDA approval of brensocatib.
In this video, the third in a 5-part series, panelists discuss data from the phase 3 ASPEN trial.
In this video, the fourth in a 5-part series, panelists discuss who may benefit from brensocatib's approval.
In this video, the last in a 5-part series, panelists discuss their future outlook on bronchiectasis management.
Advertisement
Advertisement
Trending on HCPLive
1
SimpleScreen CRC Blood Test Meets Endpoints in Clinical Validation Study
2
Liver Lineup: Bepirovirsen and the Push Toward Functional Cure in Hepatitis B
3
Eplontersen Misses Primary Endpoint in Phase 3 ATTR-CM Trial
4
Biologic Therapy for Asthma and COPD: Real-World Perspectives From APPs
5